Limits...
The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity.

Ampofo E, Später T, Müller I, Eichler H, Menger MD, Laschke MW - Mar Drugs (2015)

Bottom Line: This was associated with a decreased platelet aggregation.Fascaplysin also decreased PLA formation after PMA but not PAR-1-AP and ADP stimulation.Fascaplysin exerts anti-thrombotic activity, which represents a novel mode of action in the pleiotropic activity spectrum of this compound.

View Article: PubMed Central - PubMed

Affiliation: Institute for Clinical and Experimental Surgery, Saarland University, 66421 Homburg/Saar, Germany. emmanuel.ampofo@uks.eu.

ABSTRACT

Background: The marine-derived kinase inhibitor fascaplysin down-regulates the PI3K pathway in cancer cells. Since this pathway also plays an essential role in platelet signaling, we herein investigated the effect of fascaplysin on thrombosis.

Methods: Fascaplysin effects on platelet activation, platelet aggregation and platelet-leukocyte aggregates (PLA) formation were analyzed by flow cytometry. Mouse dorsal skinfold chambers were used to determine in vivo the effect of fascaplysin on photochemically induced thrombus formation and tail-vein bleeding time.

Results: Pre-treatment of platelets with fascaplysin reduced the activation of glycoprotein (GP)IIb/IIIa after protease-activated receptor-1-activating peptide (PAR-1-AP), adenosine diphosphate (ADP) and phorbol-12-myristate-13-acetate (PMA) stimulation, but did not markedly affect the expression of P-selectin. This was associated with a decreased platelet aggregation. Fascaplysin also decreased PLA formation after PMA but not PAR-1-AP and ADP stimulation. This may be explained by an increased expression of CD11b on leukocytes in PAR-1-AP- and ADP-treated whole blood. In the dorsal skinfold chamber model of photochemically induced thrombus formation, fascaplysin-treated mice revealed a significantly extended complete vessel occlusion time when compared to controls. Furthermore, fascaplysin increased the tail-vein bleeding time.

Conclusion: Fascaplysin exerts anti-thrombotic activity, which represents a novel mode of action in the pleiotropic activity spectrum of this compound.

Show MeSH

Related in: MedlinePlus

Effect of fascaplysin on platelet-leukocyte aggregates (PLA) formation. (A–D) Whole blood was incubated with 10 μM fascaplysin (black bars, n = 6) or vehicle (DMSO, white bars, n = 6) for 0.5 h followed by stimulation with PAR-1-AP, ADP or PMA. Data are given in % of vehicle. Unstimulated whole blood served as negative control (grey bars, n = 6). Platelets bound to all leukocytes (A) or lymphocytes (B); monocytes (C) and granulocytes (D) were assessed by flow cytometry using double fluorescence staining (CD45/CD42b). Mean ± SEM. * p < 0.05 vs. vehicle.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4663553&req=5

marinedrugs-13-06774-f004: Effect of fascaplysin on platelet-leukocyte aggregates (PLA) formation. (A–D) Whole blood was incubated with 10 μM fascaplysin (black bars, n = 6) or vehicle (DMSO, white bars, n = 6) for 0.5 h followed by stimulation with PAR-1-AP, ADP or PMA. Data are given in % of vehicle. Unstimulated whole blood served as negative control (grey bars, n = 6). Platelets bound to all leukocytes (A) or lymphocytes (B); monocytes (C) and granulocytes (D) were assessed by flow cytometry using double fluorescence staining (CD45/CD42b). Mean ± SEM. * p < 0.05 vs. vehicle.

Mentions: Besides the main initiator P-selectin, PLA formation also depends on GPIIb/IIIa [26]. Based on our finding that fascaplysin markedly diminishes agonist-induced GPIIb/IIIa activation, we next analyzed by flow cytometry whether it also affects the interaction of platelets with leukocytes. We detected an increased number of platelets bound to leukocytes after PAR-1-AP and ADP stimulation, which, however, was not influenced by fascaplysin pre-treatment. In contrast, fascaplysin caused a significant reduction of PMA-induced PLA formation (Figure 4A).


The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity.

Ampofo E, Später T, Müller I, Eichler H, Menger MD, Laschke MW - Mar Drugs (2015)

Effect of fascaplysin on platelet-leukocyte aggregates (PLA) formation. (A–D) Whole blood was incubated with 10 μM fascaplysin (black bars, n = 6) or vehicle (DMSO, white bars, n = 6) for 0.5 h followed by stimulation with PAR-1-AP, ADP or PMA. Data are given in % of vehicle. Unstimulated whole blood served as negative control (grey bars, n = 6). Platelets bound to all leukocytes (A) or lymphocytes (B); monocytes (C) and granulocytes (D) were assessed by flow cytometry using double fluorescence staining (CD45/CD42b). Mean ± SEM. * p < 0.05 vs. vehicle.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4663553&req=5

marinedrugs-13-06774-f004: Effect of fascaplysin on platelet-leukocyte aggregates (PLA) formation. (A–D) Whole blood was incubated with 10 μM fascaplysin (black bars, n = 6) or vehicle (DMSO, white bars, n = 6) for 0.5 h followed by stimulation with PAR-1-AP, ADP or PMA. Data are given in % of vehicle. Unstimulated whole blood served as negative control (grey bars, n = 6). Platelets bound to all leukocytes (A) or lymphocytes (B); monocytes (C) and granulocytes (D) were assessed by flow cytometry using double fluorescence staining (CD45/CD42b). Mean ± SEM. * p < 0.05 vs. vehicle.
Mentions: Besides the main initiator P-selectin, PLA formation also depends on GPIIb/IIIa [26]. Based on our finding that fascaplysin markedly diminishes agonist-induced GPIIb/IIIa activation, we next analyzed by flow cytometry whether it also affects the interaction of platelets with leukocytes. We detected an increased number of platelets bound to leukocytes after PAR-1-AP and ADP stimulation, which, however, was not influenced by fascaplysin pre-treatment. In contrast, fascaplysin caused a significant reduction of PMA-induced PLA formation (Figure 4A).

Bottom Line: This was associated with a decreased platelet aggregation.Fascaplysin also decreased PLA formation after PMA but not PAR-1-AP and ADP stimulation.Fascaplysin exerts anti-thrombotic activity, which represents a novel mode of action in the pleiotropic activity spectrum of this compound.

View Article: PubMed Central - PubMed

Affiliation: Institute for Clinical and Experimental Surgery, Saarland University, 66421 Homburg/Saar, Germany. emmanuel.ampofo@uks.eu.

ABSTRACT

Background: The marine-derived kinase inhibitor fascaplysin down-regulates the PI3K pathway in cancer cells. Since this pathway also plays an essential role in platelet signaling, we herein investigated the effect of fascaplysin on thrombosis.

Methods: Fascaplysin effects on platelet activation, platelet aggregation and platelet-leukocyte aggregates (PLA) formation were analyzed by flow cytometry. Mouse dorsal skinfold chambers were used to determine in vivo the effect of fascaplysin on photochemically induced thrombus formation and tail-vein bleeding time.

Results: Pre-treatment of platelets with fascaplysin reduced the activation of glycoprotein (GP)IIb/IIIa after protease-activated receptor-1-activating peptide (PAR-1-AP), adenosine diphosphate (ADP) and phorbol-12-myristate-13-acetate (PMA) stimulation, but did not markedly affect the expression of P-selectin. This was associated with a decreased platelet aggregation. Fascaplysin also decreased PLA formation after PMA but not PAR-1-AP and ADP stimulation. This may be explained by an increased expression of CD11b on leukocytes in PAR-1-AP- and ADP-treated whole blood. In the dorsal skinfold chamber model of photochemically induced thrombus formation, fascaplysin-treated mice revealed a significantly extended complete vessel occlusion time when compared to controls. Furthermore, fascaplysin increased the tail-vein bleeding time.

Conclusion: Fascaplysin exerts anti-thrombotic activity, which represents a novel mode of action in the pleiotropic activity spectrum of this compound.

Show MeSH
Related in: MedlinePlus